Stay updated on Biomarker Response to Immunotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:57:00.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a Phase II clinical trial for immunotherapy drugs ipilimumab and nivolumab, and the addition of a new revision number and collaborators.
    Difference
    44%
    Check dated 2025-04-16T02:13:55.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T23:46:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T18:51:33.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page has updated the names of key individuals and the dates associated with updates, replacing Mark Awad, MD with Biagio Ricciuti and changing the last update dates to March 2025.
    Difference
    1%
    Check dated 2025-03-25T13:11:16.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:26:12.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Immunotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.